Statin therapy most beneficial for patients with high genetic risk
Patients with a high genetic risk of heart attack benefit more from statin therapy than those in intermediate and low-risk categories, according to research published in The Lancet. Although past research consistently showed that statins provide about the same relative risk reduction across all categories of patients, the researchers did find a difference in the effect of statin therapy by looking specifically at genetic risk factors. Continue reading
